McKesson (NYSE:MCK) CAO Napoleon Rutledge, Jr. Sells 328 Shares of Stock

McKesson Corporation (NYSE:MCK) CAO Napoleon Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

McKesson Price Performance

McKesson stock opened at $962.08 on Tuesday. The stock has a market cap of $117.85 billion, a price-to-earnings ratio of 27.67, a price-to-earnings-growth ratio of 1.52 and a beta of 0.40. The firm has a 50-day moving average of $830.53 and a two-hundred day moving average of $782.30. McKesson Corporation has a 1 year low of $583.55 and a 1 year high of $971.93.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter in the previous year, the firm posted $8.03 earnings per share. The company’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. McKesson’s dividend payout ratio is presently 9.43%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Brighton Jones LLC increased its holdings in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after acquiring an additional 798 shares in the last quarter. Caxton Associates LLP purchased a new stake in McKesson during the 1st quarter worth approximately $233,000. Sivia Capital Partners LLC increased its stake in McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after purchasing an additional 300 shares in the last quarter. Callan Family Office LLC raised its holdings in shares of McKesson by 175.7% in the second quarter. Callan Family Office LLC now owns 2,321 shares of the company’s stock worth $1,701,000 after buying an additional 1,479 shares during the last quarter. Finally, IFP Advisors Inc raised its holdings in shares of McKesson by 44.5% in the second quarter. IFP Advisors Inc now owns 2,655 shares of the company’s stock worth $1,963,000 after buying an additional 817 shares during the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently weighed in on MCK. Jefferies Financial Group upped their price objective on shares of McKesson from $820.00 to $900.00 and gave the stock a “buy” rating in a research note on Monday, October 13th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. TD Cowen lifted their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday. Wall Street Zen downgraded shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Wells Fargo & Company increased their target price on McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, McKesson has an average rating of “Moderate Buy” and a consensus target price of $918.93.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.